Portfolio company
DNA1
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a platform for relating phenotype to genotype to accelerate discoveries in diagnostics, precision medicine, and genetics for healthcare organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Healthcare insights platform
This company provides a data analytics platform that integrates genetic information and clinical research to assist pharmaceutical firms in developing precision medicine and treatments.
intoDNA
This company develops an AI-powered platform for detecting and quantifying DNA damage in cells to support pharmaceutical companies with drug development and diagnostics.
FDNA
This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.
Healthcare data platform
This company develops a cloud-based data platform that unifies patient records and clinical information for healthcare providers, insurance payers, and life sciences organisations.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Sano Genetics
This company provides a software platform connecting patients with chronic conditions to pharmaceutical researchers for precision medicine clinical trials and genetic testing.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
Place Genomics
This company develops DNA nanotechnology and genomic analysis tools for researchers and healthcare providers to advance precision medicine and genetic research.
